Jin Wei Wu
Director/Board Member at Taizhou Juhe Investment Co. Ltd.
Profile
Jin Wei Wu is currently an Executive Director at Taizhou Juhe Investment Co. Ltd.
Previously, Wu held positions as Director & Deputy General Manager at Zhejiang Starry Pharmaceutical Co., Ltd.
and as General Manager & Executive Director at Shanghai Starry Pharmaceutical Co., Ltd.
Jin Wei Wu active positions
Companies | Position | Start |
---|---|---|
Taizhou Juhe Investment Co. Ltd.
Taizhou Juhe Investment Co. Ltd. Financial ConglomeratesFinance Taizhou Juhe Investment Co. Ltd. is a private company that provides investment services. The company is based in Taizhou, China. and has subsidiaries in China. | Director/Board Member | - |
Former positions of Jin Wei Wu
Companies | Position | End |
---|---|---|
Shanghai Starry Pharmaceutical Co., Ltd.
Shanghai Starry Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Starry Pharmaceutical Co., Ltd. engages in development and production of non-ionic contrast agent diagnostic drug preparations. Its four production lines include high-volume injection, small-volume injection, cream (hormonal), and cream and gel. The company was founded on June 5, 2012 and is headquartered in Shanghai, China. | Chief Executive Officer | 2016-12-27 |
ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD. | Director/Board Member | - |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD. | Health Technology |
Private companies | 2 |
---|---|
Taizhou Juhe Investment Co. Ltd.
Taizhou Juhe Investment Co. Ltd. Financial ConglomeratesFinance Taizhou Juhe Investment Co. Ltd. is a private company that provides investment services. The company is based in Taizhou, China. and has subsidiaries in China. | Finance |
Shanghai Starry Pharmaceutical Co., Ltd.
Shanghai Starry Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Starry Pharmaceutical Co., Ltd. engages in development and production of non-ionic contrast agent diagnostic drug preparations. Its four production lines include high-volume injection, small-volume injection, cream (hormonal), and cream and gel. The company was founded on June 5, 2012 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Jin Wei Wu